Despite the need for the development of effective immunotherapies for the treatment of CLL, as well the recently unraveled promise of IL-27 in cancer therapeutics, the role of IL-27 in the development and progression of CLL remained largely unexplored. Here, IL27 is linked to B-cell chronic lymphocytic leukemia.